|
|
Symposia,
Exhibitions, and Congresses
We also are willing to collaborate in research projects. Areas that we already collaborate in include wound care, ophthalmology, cost-effectiveness of medical interventions, evidence-based medicine, oncology and nutrition, and infectious diseases.
Here
are some of the fruits of our latest research--papers recently published
or in press:
·Fife CE, Carter MJ, Walker D, Thomson B.
Wound care outcomes and associated cost among patients treated in U.S. outpatient
wound centers: Data from the U.S. Wound Registry. Wounds. 2012; in press.
·Fife CE, Wall V, Carter MJ, Walker D, Thomson B. Is there a relationship
between physician and facility billed level of service in outpatient wound
centers? Ostomy Wound Manage. 2012; in press.
·Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson
J. Analysis of run-in and treatment data in a wound outcomes registry: clinical
impact of topical platelet-rich plasma gel on healing trajectory. Int
Wound J. 2011 Dec;8(6):638-650.
·Carter MJ, Limburg H, Lansingh VC, Silva JC, Resnikoff S. Do gender
inequities exist in Latin America in regard to cataract surgical coverage?
A meta-analysis. Clin Exp Ophthalmol 2011; 2011 Oct 17. [Epub
ahead of print]
·Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel
on wound healing: A systematic review and meta-analysis. ePlasty
2011;11:e38.
·Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Peña BN,
Ghersi HA, Bote PL, Nano ME, Silva JC. Causes of blindness and visual impairment
in Latin America. Survey Ophthalmol 2011 Nov 30. [Epub
ahead of print]
·de Leon J, Driver VR, Fylling C, Carter MJ, Anderson C, Wilson J,
Dougherty RM, Fuston D, Trigilia D, Valenski V, Rappl LM. The clinical relevance
of treating chronic wounds with an enhanced near-physiological concentration
of platelet rich plasma (PRP) gel. Adv
Skin Wound Care 2011; 24(8):357-68.
·Lansingh VC, Carter MJ. State of the globe: the unglamorous side
of infectious diseases: parasites. Glob
Infect Dis 2011;3:113-4.
·Warriner RA 3rd, Carter MJ. The current state of evidence-based
protocols in wound care. Plast
Reconstr Surg 2011;127 Suppl 1:144S-153S.
·Carter MJ. Cost-effectiveness research in wound care: Definitions,
approaches, and limitations. Ostomy
Wound Manage 2010;56:48-59.
•Carter MJ. Evidence-based medicine: An overview of key concepts.
Ostomy
Wound Manage 2010;56:68-85.
•Fife CE, Carter MJ, Walker D, Thomson B. A retrospective data analysis
of antimicrobial dressing usage in 3,084 patients. Ostomy
Wound Manage 2010;56:2842.
•Fife CE, Maus EA, Carter MJ. Lipedema: A frequently misdiagnosed
and misunderstood fatty deposition syndrome. Adv
Skin Wound Care 2010 ;23:81-92; quiz 93-4.
•Lansingh VC, Resnikoff S, Tingley-Kelley K, Nano ME, Martens M, Silva
JC, Duerksen R, Carter MJ. Cataract surgery rates in Latin America: a four-year
longitudinal study of 19 countries. Ophthalmic
Epidemiology 2010;17:75-81.
•Fife CE, Carter MJ. Lymphoedema in bariatric patients. J
Lymphoedema 2009;4:29-37.
•Carter MJ, Fife CE, Walker D, Thomson B. Estimating the applicability
of wound-care randomized controlled trials to general wound care populations
by estimating the percentage of individuals excluded from a typical wound
care population in such trials. Adv
Skin Wound care 2009; 22:316-24. Winner of the
2009 Roberta Abruzzese Publishing Award.
•Quiroga L, Lansingh VC, Samudio M, Peña FY, Carter MJ. Characteristics
of the corneal endothelium
and pseudoexfoliation syndrome in patients with senile cataract. Clin
Exp Ophthalmol 2010;38:449-55.
Over
the last several years we have critiqued hundreds of clinical studies either
informally or as part of a systematic review. In every instance we have
come across problems—some small, but many that can be regarded as
design flaws. We cannot fix design flaws! What we can do, however, is help
you plan a study so that it doesn’t have any.
Click on our Clinical Design of Studies page.
